SCHEMBL13907960

SCHEMBL13907960

Cc1cc(C(=O)O)cc2[nH]c(=O)[nH]c12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TPMT P51580 1/20 0.42
ALDH1A1 P00352 2/20 0.41
LMNA P02545 2/20 0.41
GRIK1 P39086 1/20 0.41
GRIA1 P42261 1/20 0.41
GRIA2 P42262 1/20 0.41
GRIA3 P42263 1/20 0.41
GRIA4 P48058 1/20 0.41
HSD17B10 Q99714 2/20 0.40
HSP90AA1 P07900 1/20 0.40
ESR2 Q92731 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
GRIN2D O15399 1/20 0.40
GRIN3B O60391 1/20 0.40
GRIN1 Q05586 1/20 0.40
GRIN2A Q12879 1/20 0.40
GRIN2B Q13224 1/20 0.40
GRIN2C Q14957 1/20 0.40
GRIN3A Q8TCU5 1/20 0.40
TTR P02766 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13907978 0.81 BCL6 (0.45) ALDH1A1LMNAHSD17B10TDP1BCL6
SCHEMBL27311098 0.80 LMNA (0.40) ALDH1A1LMNAHSD17B10TDP1TTR
SCHEMBL6363474 0.80 ALDH1A1 (0.40) TPMTALDH1A1LMNAGRIK1HSD17B10
SCHEMBL1758988 0.80 TTR (0.47) TPMTALDH1A1LMNAGRIK1TTR
SCHEMBL1759139 0.80 BCL6 (0.50) TPMTALDH1A1LMNAHSD17B10TDP1
SCHEMBL27311310 0.80 CA12 (0.51) TPMTALDH1A1LMNAGRIN2DGRIN3B
SCHEMBL6362927 0.75 TDP1 (0.42) TPMTALDH1A1LMNATDP1GRIN2D
SCHEMBL2257694 0.74 GRIN2D (0.69) ALDH1A1GRIA1HSD17B10GRIN2DGRIN3B
SCHEMBL3965692 0.74 KDM4E (0.41) ALDH1A1GRIA1HSD17B10GRIN2DGRIN3B
SCHEMBL1095502 0.71 SIRT2 (0.69) ALDH1A1LMNAGRIK1GRIA1GRIA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009034029-A2 1-SUBSTITUTED 4-HETEROCYCLYLPIPERIDINES FOR USE AS CGRP ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-03-19 WO disclosed